BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26805273)

  • 1. [A Case of Taxane-Pretreated Metastatic Gastric Cancer with Excellent Response to Nab-Paclitaxel].
    Kawabata R; Kimura Y; Kawase T; Yoshikawa M; Kameda C; Matsumura T; Koga C; Murakami M; Hirota M; Noura S; Ikenaga M; Shimizu J; Hasegawa J
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2088-90. PubMed ID: 26805273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients.
    Fabi A; Giannarelli D; Malaguti P; Ferretti G; Vari S; Papaldo P; Nisticò C; Caterino M; De Vita R; Mottolese M; Iacorossi L; Cognetti F
    Drug Des Devel Ther; 2015; 9():6177-83. PubMed ID: 26640370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of advanced gastric cancer in which paclitaxel proved effective after resistance to docetaxel].
    Tsushima T; Tsuji Y; Abe S; Tanaka S; Tamura F; Mizushima T; Makino K; Oura K; Honda K; Sumiyoshi T; Yoshizaki N; Kondo H
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1647-50. PubMed ID: 17940382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A patient with paclitaxel hypersensitivity treated with nab-paclitaxel].
    Ouchi A; Ouchi A; Asano M; Aono K; Watanabe T; Kato T
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):889-91. PubMed ID: 25131878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Experience with Nab-Paclitaxel for Patients with Advanced Gastric Cancer: Safety and Efficacy.
    Kanazawa Y; Fujita I; Kakinuma D; Arai H; Matsuno K; Shimoda T; Ko K; Kato S; Uchida E
    Anticancer Res; 2017 May; 37(5):2715-2720. PubMed ID: 28476850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case of advanced gastric cancer successfully treated with chemotherapy of weekly paclitaxel].
    Fujii K; Uno H; Kayo S; Ueda Y; Kawamura C; Mizuyama Y; Kaneda K; Nakagawa H; Arakawa T
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1107-9. PubMed ID: 17637550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outcome and Problems of Nab-Paclitaxel Therapy for Gastric Cancer in Clinical Practice].
    Doi T; Ishikawa T; Okayama T; Dohi O; Yoshida N; Kamada K; Katada K; Sogame Y; Uchiyama K; Handa O; Takagi T; Yasuda H; Sakagami J; Konishi H; Naito Y; Itoh Y
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):211-4. PubMed ID: 27067684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile.
    González-Martín A; Alba E; Ciruelos E; Cortés J; Llombart A; Lluch A; Andrés R; Álvarez I; Aramendía JM; de la Peña FA; Barnadas A; Batista N; Calvo L; Galve E; García-Palomo A; García-Sáenz JÁ; de la Haba J; López R; López-Vivanco G; Martínez-Jáñez N; de Dueñas EM; Plazaola A; Rodríguez-Lescure Á; Ruiz M; Sánchez-Rovira P; Santaballa A; Seguí MÁ; Tusquets I; Zamora P; Martín M
    Curr Cancer Drug Targets; 2016; 16(5):415-28. PubMed ID: 26278712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of supportive care for albumin-bound paclitaxel(nab-paclitaxel)in 20 patients with metastatic breast cancer].
    Yamada C; Yonezawa M; Shimizu Y; Taga R; Kashihara H; Tsuji K; Murata T; Yoshino H
    Gan To Kagaku Ryoho; 2014 Jan; 41(1):77-81. PubMed ID: 24423956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of
    Awasthi N; Schwarz MA; Zhang C; Schwarz RE
    Mol Cancer Ther; 2018 Nov; 17(11):2353-2364. PubMed ID: 30166402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer.
    Teneriello MG; Tseng PC; Crozier M; Encarnacion C; Hancock K; Messing MJ; Boehm KA; Williams A; Asmar L
    J Clin Oncol; 2009 Mar; 27(9):1426-31. PubMed ID: 19224848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-resistant recurrent gastric cancer responsive to docetaxel: a case report.
    Kimura Y; Imasato M; Yano H; Taniguchi H; Danno K; Kanoh T; Ohnishi T; Tono T; Nakano Y; Monden T; Imaoka S
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):643-5. PubMed ID: 21498996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nearly Complete Response after Second-Line Therapy with Nab-Paclitaxel Monotherapy in a Patient with Recurrent Advanced Non-Small Cell Lung Cancer].
    Shimizu M; Miya T; Takahashi A; Kobayashi Y; Kubota K; Gemma A; Hirose T
    Gan To Kagaku Ryoho; 2017 Aug; 44(8):699-702. PubMed ID: 28860444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA
    Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy].
    Jingu K; Sasagawa K; Kagaya A; Ochiai T
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2117-20. PubMed ID: 16352940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of liver metastases from gastric cancer successfully treated with weekly paclitaxel chemotherapy].
    Okada K; Ebisui C; Murakami M; Yanagisawa T; Okamura S; Murata K; Yokouchi H; Tamai M; Kinuta M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2348-50. PubMed ID: 23268073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irinotecan and paclitaxel in metastatic adenocarcinoma of the esophagus and gastric cardia.
    Hecht JR; Blanke CD; Benson AB; Lenz HJ
    Oncology (Williston Park); 2003 Sep; 17(9 Suppl 8):13-5. PubMed ID: 14569841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. nab-paclitaxel: a novel formulation of taxane for treatment of breast cancer.
    Vishnu P; Roy V
    Womens Health (Lond); 2010 Jul; 6(4):495-506. PubMed ID: 20597612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma.
    Kim ES; Kies MS; Fossella FV; Glisson BS; Zaknoen S; Statkevich P; Munden RF; Summey C; Pisters KM; Papadimitrakopoulou V; Tighiouart M; Rogatko A; Khuri FR
    Cancer; 2005 Aug; 104(3):561-9. PubMed ID: 16028213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Options for primary chemotherapy of epithelial ovarian cancer: taxanes.
    Trimble EL; Arbuck SG; McGuire WP
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S114-21. PubMed ID: 7835794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.